Arkolith/Insider Trading/FTH/Form 4/A

Parikh Anand Kiran

President and CEO, DirectorSensei Biotherapeutics, Inc. (FTH) · full profile →Form 4/A · filed Jun 16, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 17, 2026Grant(A)761——761K
Feb 17, 2026Grant(A)12K——12K
Feb 17, 2026Grant(A)137K——137K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0002111813-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML